Overview: Rapid Plasma Reagin TestIntroduction: The Rapid Plasma Reagin Test detects syphilis antibodies to diagnose syphilis, causing sores or rash. Following 2023 CDC guidelines, it uses immunoassays for high specificity, supporting infection screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in serology for patients with suspected syphilis.
Other Names: RPR Assay, Syphilis Screening Test.
FDA Status: Laboratory-developed test (LDT), meeting serology standards for diagnostic accuracy.
Historical Milestone: RPR testing began in the 1940s with syphilis research. Immunoassay methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Detects syphilis antibodies to diagnose syphilis, guides treatment, and evaluates patients with sores or rash.
Test Parameters: 1. Syphilis Antibodies
Pretest Condition: No fasting required. Collect serum. Report history of sores, rash, or sexual exposure.
Specimen: Serum (SST, 2-5 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document sores, rash, or history of sexually transmitted infections. Include current medications, especially antibiotics.
Consent: Written consent required, detailing the tests purpose, syphilis implications, and risks of sample collection.
Procedural Considerations: Uses flocculation to detect syphilis antibodies. Results are available in 1-2 days, supporting clinical decisions. Performed in laboratories, often for syphilis screening.
Factors Affecting Result Accuracy: Sample hemolysis or improper storage can affect results. Other treponemal infections may cause false positives.
Clinical Significance: Positive RPR confirms syphilis, guiding penicillin therapy. Negative results may require confirmatory treponemal testing.
Specialist Consultation: Consult an infectious disease specialist for result interpretation and treatment planning.
Additional Supporting Tests: Treponemal antibody tests, darkfield microscopy, or PCR to confirm syphilis diagnosis.
Test Limitations: Non-specific for syphilis; clinical correlation is needed. Sample quality affects sensitivity.
References: CDC Syphilis Guidelines, 2023; Sexually Transmitted Diseases, Workowski KA, 2022.
